Your browser doesn't support javascript.
loading
Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease.
Yeung, Patrick K K; Lai, Angela K W; Son, Hyo Jin; Zhang, Xu; Hwang, Onyou; Chung, Stephen S M; Chung, Sookja K.
Affiliation
  • Yeung PKK; School of Biomedical Sciences, The University of Hong Kong, Hong Kong SAR, China.
  • Lai AKW; School of Biomedical Sciences, The University of Hong Kong, Hong Kong SAR, China.
  • Son HJ; Department of Biochemistry, University of Ulsan College of Medicine, Seoul, Korea.
  • Zhang X; School of Biomedical Sciences, The University of Hong Kong, Hong Kong SAR, China.
  • Hwang O; Department of Biochemistry, University of Ulsan College of Medicine, Seoul, Korea.
  • Chung SSM; Division of Science and Technology, United International College, Zhuhai, Guandong, China.
  • Chung SK; School of Biomedical Sciences, The University of Hong Kong, Hong Kong SAR, China; Research Center of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: skchung@hkucc.hku.hk.
Neurobiol Aging ; 50: 119-133, 2017 02.
Article in En | MEDLINE | ID: mdl-27960106
ABSTRACT
Fungicide exposure causes degeneration of dopaminergic neurons and contributes to Parkinson's disease (PD). Benomyl inhibits enzymes responsible for detoxifying the reactive dopamine metabolite 3,4-dihydroxyphenylacetaldehyde. Aldose reductase (AR) is known as tetrahydrobiopterin (BH4) reductase that generates BH4, a cofactor for tyrosine hydroxylase (TH) involved in dopamine synthesis. AR also acts as an aldehyde reductase involved in detoxifying 3,4-dihydroxyphenylacetaldehyde. In PD patients, the level of AR is significantly lower in the cerebellum. To determine if AR deficiency contributes to PD, AR wild-type (AR+/+) and knockout (AR-/-) mice were administrated with 1-methyl-4-phenyl -1,2,3,6- tetrahydropyridine (MPTP). The MPTP-treated AR-/- mice showed more severe behavioral deficits and brain damage than that of AR+/+ mice. Contrary to expectation, under normal or MPTP-treated condition, AR-/- mice showed a significant elevation of BH4 and dopamine in the midbrain, suggesting that either AR does not contribute to BH4 production, or other BH4 synthetic pathways are induced. The AR-/- brain showed upregulation of peroxynitrite, inducible nitric oxide synthase and downregulation of antioxidant enzymes, Cu/Zn superoxide dismutase (SOD) and peroxiredoxin 2 (Prx2), which indicate an increase in oxidative stress. In line with the animal data, pretreating the SH-SY5Y cells with AR inhibitors (Fidarestat or Epalrestat) before MPP+ treatment, increased severe cell death and mitochondrial fragmentation with downregulation of SOD were observed when compared to the MPP+ treatment alone. Cycloxygenase 2 (COX2), which can lead to the oxidation of dopamine, was upregulated in AR-/- brains. Autophagic proteins, beclin-1 and LC3B were also downregulated. The loss of dopaminergic neurons was associated with activation of p-ERK1/2. These findings suggest that AR plays an important role in protecting dopaminergic neuron against neurotoxic metabolites in PD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Autophagy / Aldehyde Reductase / Oxidative Stress / Dopaminergic Neurons Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Autophagy / Aldehyde Reductase / Oxidative Stress / Dopaminergic Neurons Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Affiliation country: China